#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Gaucher's disease type III Non-Hodgkin's lymphoma refractory Congenital generalised lipodystrophy Small cell lung cancer limited stage Ocular lymphoma Netherton's syndrome Leukocyte adhesion deficiency Small intestine leiomyosarcoma Alexander disease Rett syndrome Leukoencephalopathy Non-small cell lung cancer recurrent Hypomagnesaemia Haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Treatment Breast angiosarcoma metastatic Encephalitis autoimmune – Treatment Congenital nephrogenic diabetes insipidus – Diagnostics Idiopathic inflammatory myopathy – Treatment Biotinidase deficiency – Treatment Myxofibrosarcoma – Life with Disease Soft tissue sarcoma – Diagnostics Haemophilia A with anti factor VIII – Diagnostics Alternating hemiplegia of childhood – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alanyl Glutamine [18F]Mc225 S095035 Erenumab Hydrocortisone Berzosertib Potassium Iodide Bi 764532 Munc-T3 Testosterone Undecanoate Chlorambucil Immunglobulin Formoterol Fumarate Dihydrate Dexketoprofen Ivabradine Hydrochloride Inupadenant Maraviroc Nafarelin CITRIC ACID ANHYDROUS Azd5863 More therapies…

    Learn about Your Condition

    Breast cancer stage II Cardiomyopathy Herpes simplex meningitis Spinal osteoarthritis Menopausal symptoms Mantle cell lymphoma stage IV Anal abscess Cholangiocarcinoma Altered state of consciousness Stevens-Johnson syndrome Osteosarcoma recurrent Affective disorder Insomnia Non-obstructive cardiomyopathy Polyneuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Paclitaxel
    • Pembrolizumab
    France Spain

  • Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Carboplatin
    • Etoposide
    France

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Leuprorelin Acetate
    Belgium France Ireland Spain

  • Study on Reducing JAK Inhibitor Doses in Patients with Low Disease Activity in Rheumatoid Arthritis Using Tofacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Filgotinib
    • Tofacitinib
    France

  • Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Disodium Folinate
    • Rucaparib
    • Trametinib
    Austria Belgium Czechia France Germany Greece +4

  • Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tucatinib
    • Bevacizumab
    • Cetuximab
    Austria Belgium France Germany Greece Hungary +8

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aprepitant
    • Ondansetron
    • Pacritinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Niraparib
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    Belgium France Italy Spain

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Renal transplant
    Investigated Drugs:
    • Rituximab
    France
Previous Page
1 … 14 15 16 17 18 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!